Abstract
A new chemical approach to synthesizing human ABO histo-blood type 2 antigenic determinants was developed. N-Phthaloyl-protected lactosaminyl thioglycoside derived from lactulose via the Heyns rearrangement was employed to obtain a type 2 core disaccharide. Use of this scheme lowered the overall number of reaction steps. Stereoselective construction of the α-galactosaminide/galactoside found in A- and B-antigens, respectively, was achieved by using a unique di-tert-butylsilylene-directed α-glycosylation method. The proposed synthetic scheme provides an alternative to existing procedures for preparing ABO blood group antigens.
Highlights
ABO histo-blood group antigens are expressed on red blood cells and are widely distributed in various tissues such as the vascular endothelium, where they are displayed on plasmalemmal glycoproteins and glycolipids by attachment to sugar residues that terminate N-linked, O-linked, and lipid-linked glycans [1,2]
2)]Gal, Galα(1-3)[Fucα(1-2)]Gal, and Fucα(1-2)Gal glycan structures, respectively. These antigens can be further divided into six subtypes based on linkage arrangement: type 1, ABO-β(1-3)GlcNAcβ; type 2, ABO-β(1-4)GlcNAcβ; type 3, ABO-β(1-4)GalNAcα; type 4, ABO-β(1-3)GalNAcβ; type 5, ABO-β(1-3)Galβ; and type 6: ABO-β(1-4)Glcβ [3,4]
We have developed a novel approach to synthesizing human histo-blood group type 2 antigens
Summary
ABO histo-blood group antigens are expressed on red blood cells and are widely distributed in various tissues such as the vascular endothelium, where they are displayed on plasmalemmal glycoproteins and glycolipids by attachment to sugar residues that terminate N-linked, O-linked, and lipid-linked glycans [1,2]. 2)]Gal, Galα(1-3)[Fucα(1-2)]Gal, and Fucα(1-2)Gal glycan structures, respectively. These antigens can be further divided into six subtypes based on linkage arrangement: type 1, ABO-β(1-3)GlcNAcβ; type 2, ABO-β(1-4)GlcNAcβ; type 3, ABO-β(1-4)GalNAcα; type 4, ABO-β(1-3)GalNAcβ; type 5, ABO-β(1-3)Galβ; and type 6: ABO-β(1-4)Glcβ [3,4]. We envisioned that chemically synthesized pure samples would enable a range of studies on the physiological and pathological implications of ABO group antigens. The goal of our research is to develop a facile synthetic route to ABO histo-blood group antigens, type 2 glycans. We describe a new chemical approach to ABO group type 2 antigens with a pentylamine linker (1‒3; Figure 1), which are expected to be useful in future biological studies
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
